USE OF HIGH-DOSE METHOTREXATE (HD-MTX) IN LEPTOMENINGEAL METASTASIS (LM) IN PATIENTS WITH BREAST CANCER

被引：0
|
作者：
Tsyvkin, Elina [1 ]
Rauschkolb, Paula [2 ]
Pentsova, Elena [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Intermt Med Grp, Murray, UT USA
来源：
NEURO-ONCOLOGY | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [21] EFFECT OF INTRAVENOUS HIGH-DOSE METHOTREXATE (IV HD-MTX) ON REGIONAL CEREBRAL GLUCOSE METABOLIC-RATE (RCMRGLU) IN THE RAT
    PHILLIPS, P
    ALLEN, J
    ROTTENBERG, DA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 371 - 371
  • [22] Evaluation of the pharmacokinetics of high doses of methotrexate administration (HD-MTX) in pediatric patients with osteosarcoma
    Morales, Jorge
    Villarroel, Milena
    Inostroza, Viviana
    Concha, Emma
    PHARMACY WORLD & SCIENCE, 2010, 32 (02): : 288 - 289
  • [23] HIGH-DOSE METHOTREXATE (HD-MTX) WITH CITROVORUM FACTOR (CF) RESCUE IN UNDIFFERENTIATED LARGE CELL-CARCINOMA (LCC) OF THE LUNG
    BHASKAR, B
    SHEEHY, PF
    SLATER, LM
    ARMENTROUT, SA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 110 - 110
  • [24] Influence of high-dose meth trexate therapy (HD-MTX) on glomerular and tubular kidney function
    Hempel, L
    Misselwitz, J
    Fleck, C
    Kentouche, K
    Leder, C
    Appenroth, D
    Rost, M
    Zintl, F
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 40 (06): : 348 - 354
  • [25] Treatment of Recurrent Post-transplant Lymphoproliferative Disorder (PTLD) of the Central Nervous System (CNS) with High-dose Methotrexate (HD-MTX)
    Twist, C. J.
    Kjelson, L.
    McKenney, A.
    Bonham, C. A.
    Esquivel, C.
    Castillo, R. O.
    XI INTERNATIONAL SMALL BOWEL TRANSPLANT SYMPOSIUM, 2009, : 116 - 121
  • [26] DOSAGE PREDICTIONS IN HIGH-DOSE METHOTREXATE (HD-MTX) INFUSION - EVALUATION OF THE CLASSICAL TEST-DOSE (TD) PROTOCOL AND BAYESIAN-ESTIMATION (BE) IMPROVEMENTS
    BRUNO, R
    IMBERT, AM
    ILIADIS, A
    FAVRE, R
    LENA, N
    CATALIN, J
    CARCASSONNE, Y
    CANO, JP
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) : 184 - 184
  • [27] High-dose methotrexate (HD-MTX) as CNS prophylaxis significantly improves outcome in patients with high-risk diffuse large B-cell lymphoma (DLBCL)
    Calimeri, T.
    Cecchetti, C.
    Vignati, A.
    Sassone, M.
    Foppoli, M.
    Scarfo, L.
    Ponzoni, M.
    Ferreri, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [28] Effects of carboxypeptidase G2 (CPG2) rescue in 30 lymphoma patients with high-dose methotrexate (HD-MTX) induced renal failure
    Schwartz, S
    Borner, K
    Korfel, A
    Auton, T
    Thiel, E
    ANNALS OF ONCOLOGY, 2005, 16 : 136 - 137
  • [29] PHARMACOLOGIC STUDIES DURING HIGH DOSE METHOTREXATE (HD-MTX) WITH CITROVORUM FACTOR (CF) THERAPY OF ADVANCED CANCERS
    ISACOFF, W
    EILBER, F
    PEALE, A
    BLOCK, JB
    CLINICAL RESEARCH, 1976, 24 (02): : A120 - A120
  • [30] PILOT STUDY OF REPEATED PLANNED GLUCARPIDASE FOLLOWING HIGH DOSE METHOTREXATE (HD-MTX) IN CNS LYMPHOMA (CNSL)
    Schaff, Lauren
    Lobbous, Mina
    Sener, Ugur
    Gavrilovic, Igor
    Miller, Alexandra
    Stone, Jacqueline
    Piotrowski, Anna
    Skakodub, Anna
    Madzsar, Juli
    Schumpp, Alyssa
    Acosta, Edward
    Ryan, Kevin
    Carlow, Dean
    DeAngelis, Lisa
    Nabors, Louis
    Grommes, Christian
    NEURO-ONCOLOGY, 2020, 22 : 56 - 56
12345